课题基金 / 基金详情

The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum

The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
北卡罗来纳大学/埃默里大学创新技术中心 (iTech) 涵盖预防和护理连续体
批准号:
10399185
负责人:
Lisa B Hightow-Weidman
金额:
$400.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-01 至 2022-11-30

项目摘要

项目成果

Lisa B Hightow-Weidman的其他基金

相关文献

中文摘要
翻译
虽然艾滋病毒在美国的流行在许多年龄组中已经趋于平稳,但从2000年到2010年, 男男性行为年轻人(YMSM)(13-24岁)中新诊断出艾滋病毒的人数超过 翻了一倍2010年,YMSM占13至24岁人群新感染人数的72%,占所有感染人数的30%。 男男性接触者中的新感染者。将治疗作为预防在减少新艾滋病毒感染人数方面取得的成功 青年感染,特别是YMSM,依赖于艾滋病毒检测,抗逆转录病毒治疗(无论是 治疗和预防),坚持和艾滋病毒感染者的病毒抑制。埃默里/Emory Center 创新技术(iTech)旨在通过开展创新的、跨学科的 研究青少年艾滋病毒预防和护理的技术干预措施 美国(US)的年轻人。iTech还创建了一个基础设施, 为其他ATN项目和方案提供技术提供艾滋病毒干预措施的最佳做法, 青少年。iTech的总体目标是减少艾滋病毒对青少年生活的影响。 在美国的成年人,特别是YMSM,通过提供:1)治疗作为预防那些没有艾滋病毒,但在风险; 2)及早发现和治疗那些感染但未确诊的人; 3)采取干预措施, 减少获得和接受预防和护理服务的决定因素; 4)治疗 采取干预措施,鼓励青年坚持处理药物使用、心理健康相关问题, 污名化和剥夺公民权。为艾滋病毒/艾滋病调查人员提供必要的资源和支助 实现这些目标将由iTech核心提供:1)管理; 2)分析; 3)技术。 为了实现我们的总体目标,我们制定了以下具体目标:目标1: 在技术研究方面具有专业知识和经验的领导力,以解决基本问题 与艾滋病毒预防和护理连续体相关,指导我们的整体研究战略并促进合作 和协同作用都在我们的iTech和更广泛的ATN科学界。目标2:支持 开发和评估以创新技术为重点的干预措施, 为15-24岁的高危或受感染青年提供连续预防和护理。目标3:支持整体 通过参加ATN执行委员会并与其他U19合作, 获奖者鼓励新的协同和响应赠款申请和研究,以应对新出现的 这个领域的问题。目标4:发展和培育伙伴关系,确保社区的投入 研究的概念化、设计、实施和解释阶段。目标5。为了发展, 指导和培训临床医生和研究人员,促进创新的艾滋病毒/艾滋病研究,重点是 技术创新贯穿整个护理过程。
英文摘要
While the epidemic of HIV in the US has leveled off for many age groups, from 2000-2010, the annual number of new HIV diagnoses among young men who have sex with men (YMSM) (13-24 year old) more than doubled. In 2010, YMSM accounted for 72% of new infections among people ages 13 to 24, and 30% of all new infections among MSM. The success of treatment as prevention in reducing the number of new HIV infections among youth, and particularly YMSM, relies on HIV testing, antiretroviral treatment (both for treatment and prevention), adherence and viral suppression among those with HIV. The UNC/Emory Center for Innovative Technology (iTech) aims to impact the HIV epidemic by conducting innovative, interdisciplinary research on technology-based interventions across the HIV prevention and care continuum for adolescents and young adults in the United States (US). The iTech also creates an infrastructure to share and disseminate best practices in technology-delivered HIV interventions to other ATN projects and programs serving adolescents. The iTech overall goals seek to decrease the impact of HIV on the lives of adolescents and young adults in the US, particularly YMSM, by providing: 1) treatment as prevention for those without HIV but at risk; 2) earlier identification and treatment for those infected but undiagnosed; 3) interventions to address structural determinants that decrease access to and uptake of prevention and care services; and 4) treatment interventions to encourage adherence for youth dealing with substance use, mental health related issues, stigmatization and disenfranchisement. The necessary resources and support for HIV/AIDS investigators addressing these goals will be provided by the iTech Cores: 1) Management; 2) Analytic; and, 3) Technology. To accomplish our Overall Goals we have developed the following Specific Aims: Aim 1: To provide scientific leadership with expertise and experience in technology-based research to address fundamental questions related to the HIV prevention and care continuum, guide our overall research strategy and foster collaboration and synergy both within our iTech and with the broader ATN scientific community. Aim 2: To support the development and assessment of innovative technology-focused interventions addressing the HIV prevention and care continuum for at-risk or infected youth aged 15-24 years. Aim 3: To support the overall ATN scientific agenda by participating on the ATN Executive Committee and collaborating with other U19 awardees stimulating new synergistic and responsive grants applications and research to respond to emerging issues in this field. Aim 4: To develop and nurture partnerships that will ensure community input at all stages of conceptualization, design, implementation, and interpretation of the research. Aim 5. To develop, mentor and train clinicians and researchers to stimulate innovative HIV/AIDS research focused on technological innovation across the care continuum.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scientific Leadership Group Core
  • 批准号:
    10595900
  • 项目类别:
  • 资助金额:
    $425.15万
  • 财政年份:
    2023
  • 负责人:
    Lisa B Hightow-Weidman
  • 依托单位:
RP4 LEAP
  • 批准号:
    10595904
  • 项目类别:
  • 资助金额:
    $92.17万
  • 财政年份:
    2023
  • 负责人:
    Lisa B Hightow-Weidman
  • 依托单位:
RP5 MPT Study
  • 批准号:
    10595905
  • 项目类别:
  • 资助金额:
    $73.09万
  • 财政年份:
    2023
  • 负责人:
    Lisa B Hightow-Weidman
  • 依托单位:
RP3 PrEP Choice
  • 批准号:
    10595903
  • 项目类别:
  • 资助金额:
    $6.14万
  • 财政年份:
    2023
  • 负责人:
    Lisa B Hightow-Weidman
  • 依托单位: